Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amrix Augmentation in Fibromyalgia
NCT01041495Phase 4Terminated
- Sponsor
- Upstate Medical University
- Start
- Jun 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in fibromyalgia (FM) comparing Amrix with Placebo (2 arms). Primary endpoint: Visual Analogue Pain Scale at 8 weeks. Started Jun 2009; status: terminated.
02
Drugs
cyclobenzaprine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01041495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041495.